Back to today’s briefing

Story perspectives

Metformin May Prevent Acute Myeloid Leukaemia, Study Reveals

4/17/2025

50 5

Summary

Story summary

A groundbreaking study from the University of Cambridge reveals that metformin, a widely used diabetes medication, could hold the key to preventing acute myeloid leukaemia (AML) in high-risk patients. By targeting mitochondrial metabolism, metformin appears to hinder the growth of blood cells harboring the dangerous DNMT3A mutation. Clinical trials are now essential to explore this promising avenue further.

1 of 1

Story summary

A groundbreaking study from the University of Cambridge reveals that metformin, a widely used diabetes medication, could hold the key to preventing acute myeloid leukaemia (AML) in high-risk patients. By targeting mitochondrial metabolism, metformin appears to hinder the growth of blood cells harboring the dangerous DNMT3A mutation. Clinical trials are now essential to explore this promising avenue further.